Flamingo Therapeutics appoints new board member and more digital health hires
RNA-focused digital therapeutics company Flamingo Therapeutics added a new member to its board of directors, Dr. Ezra Cohen. Flamingo produces RNA therapies for oncology and is backed by investors such as Andera Partners, Bpifrance Large…
Continue Reading